Logo image of CNM

CORE & MAIN INC-CLASS A (CNM) Stock Fundamental Analysis

USA - NYSE:CNM - US21874C1027 - Common Stock

52.02 USD
+0.25 (+0.48%)
Last: 10/15/2025, 2:53:36 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CNM. CNM was compared to 49 industry peers in the Trading Companies & Distributors industry. CNM scores excellent on profitability, but there are some minor concerns on its financial health. CNM has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

CNM had positive earnings in the past year.
CNM had a positive operating cash flow in the past year.
CNM had positive earnings in each of the past 5 years.
Of the past 5 years CNM 4 years had a positive operating cash flow.
CNM Yearly Net Income VS EBIT VS OCF VS FCFCNM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

With a decent Return On Assets value of 6.83%, CNM is doing good in the industry, outperforming 69.39% of the companies in the same industry.
CNM's Return On Equity of 22.85% is amongst the best of the industry. CNM outperforms 83.67% of its industry peers.
CNM's Return On Invested Capital of 10.97% is fine compared to the rest of the industry. CNM outperforms 71.43% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CNM is above the industry average of 10.03%.
Industry RankSector Rank
ROA 6.83%
ROE 22.85%
ROIC 10.97%
ROA(3y)7.26%
ROA(5y)5.33%
ROE(3y)23.57%
ROE(5y)17.76%
ROIC(3y)13.05%
ROIC(5y)10.52%
CNM Yearly ROA, ROE, ROICCNM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

Looking at the Profit Margin, with a value of 5.57%, CNM is in the better half of the industry, outperforming 65.31% of the companies in the same industry.
In the last couple of years the Profit Margin of CNM has grown nicely.
The Operating Margin of CNM (9.44%) is better than 67.35% of its industry peers.
CNM's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 26.67%, CNM is in line with its industry, outperforming 42.86% of the companies in the same industry.
In the last couple of years the Gross Margin of CNM has grown nicely.
Industry RankSector Rank
OM 9.44%
PM (TTM) 5.57%
GM 26.67%
OM growth 3Y4.39%
OM growth 5Y16.07%
PM growth 3Y18.52%
PM growth 5Y35.35%
GM growth 3Y1.32%
GM growth 5Y2.7%
CNM Yearly Profit, Operating, Gross MarginsCNM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CNM is creating some value.
The number of shares outstanding for CNM has been reduced compared to 1 year ago.
CNM has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CNM is higher compared to a year ago.
CNM Yearly Shares OutstandingCNM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CNM Yearly Total Debt VS Total AssetsCNM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 3.41 indicates that CNM is not in any danger for bankruptcy at the moment.
CNM has a better Altman-Z score (3.41) than 61.22% of its industry peers.
The Debt to FCF ratio of CNM is 4.00, which is a neutral value as it means it would take CNM, 4.00 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CNM (4.00) is better than 69.39% of its industry peers.
A Debt/Equity ratio of 1.18 is on the high side and indicates that CNM has dependencies on debt financing.
The Debt to Equity ratio of CNM (1.18) is worse than 65.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF 4
Altman-Z 3.41
ROIC/WACC1.12
WACC9.82%
CNM Yearly LT Debt VS Equity VS FCFCNM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

CNM has a Current Ratio of 2.25. This indicates that CNM is financially healthy and has no problem in meeting its short term obligations.
CNM's Current ratio of 2.25 is in line compared to the rest of the industry. CNM outperforms 57.14% of its industry peers.
A Quick Ratio of 1.30 indicates that CNM should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.30, CNM is in line with its industry, outperforming 55.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.3
CNM Yearly Current Assets VS Current LiabilitesCNM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

CNM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.43%, which is quite good.
CNM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 64.38% yearly.
The Revenue has grown by 11.02% in the past year. This is quite good.
The Revenue has been growing by 17.04% on average over the past years. This is quite good.
EPS 1Y (TTM)10.43%
EPS 3Y44.94%
EPS 5Y64.38%
EPS Q2Q%29.85%
Revenue 1Y (TTM)11.02%
Revenue growth 3Y14.14%
Revenue growth 5Y17.04%
Sales Q2Q%6.57%

3.2 Future

Based on estimates for the next years, CNM will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.07% on average per year.
The Revenue is expected to grow by 4.88% on average over the next years.
EPS Next Y8.64%
EPS Next 2Y11.67%
EPS Next 3Y9.33%
EPS Next 5Y10.07%
Revenue Next Year2.59%
Revenue Next 2Y3.38%
Revenue Next 3Y3.95%
Revenue Next 5Y4.88%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CNM Yearly Revenue VS EstimatesCNM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
CNM Yearly EPS VS EstimatesCNM Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.48 indicates a rather expensive valuation of CNM.
Based on the Price/Earnings ratio, CNM is valued a bit cheaper than 63.27% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.49, CNM is valued a bit cheaper.
The Price/Forward Earnings ratio is 18.14, which indicates a rather expensive current valuation of CNM.
CNM's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of CNM to the average of the S&P500 Index (22.99), we can say CNM is valued slightly cheaper.
Industry RankSector Rank
PE 20.48
Fwd PE 18.14
CNM Price Earnings VS Forward Price EarningsCNM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CNM.
Based on the Price/Free Cash Flow ratio, CNM is valued a bit cheaper than 75.51% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.21
EV/EBITDA 13.45
CNM Per share dataCNM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of CNM may justify a higher PE ratio.
PEG (NY)2.37
PEG (5Y)0.32
EPS Next 2Y11.67%
EPS Next 3Y9.33%

More info and screens

0

5. Dividend

5.1 Amount

CNM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CORE & MAIN INC-CLASS A

NYSE:CNM (10/15/2025, 2:53:36 PM)

52.02

+0.25 (+0.48%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)09-09 2025-09-09/bmo
Earnings (Next)12-02 2025-12-02/bmo
Inst Owners110.28%
Inst Owner Change-0.03%
Ins Owners0.56%
Ins Owner Change3.79%
Market Cap10.27B
Analysts76.67
Price Target60.85 (16.97%)
Short Float %4.94%
Short Ratio3.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.35%
Min EPS beat(2)5.47%
Max EPS beat(2)9.23%
EPS beat(4)4
Avg EPS beat(4)6.98%
Min EPS beat(4)0.71%
Max EPS beat(4)12.5%
EPS beat(8)7
Avg EPS beat(8)3.71%
EPS beat(12)11
Avg EPS beat(12)5.9%
EPS beat(16)15
Avg EPS beat(16)11.78%
Revenue beat(2)1
Avg Revenue beat(2)0%
Min Revenue beat(2)-2.7%
Max Revenue beat(2)2.69%
Revenue beat(4)3
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-2.7%
Max Revenue beat(4)2.69%
Revenue beat(8)4
Avg Revenue beat(8)-0.59%
Revenue beat(12)5
Avg Revenue beat(12)-0.41%
Revenue beat(16)9
Avg Revenue beat(16)2.36%
PT rev (1m)-9.14%
PT rev (3m)-5.41%
EPS NQ rev (1m)-0.8%
EPS NQ rev (3m)-2.36%
EPS NY rev (1m)-0.41%
EPS NY rev (3m)-0.78%
Revenue NQ rev (1m)-1.28%
Revenue NQ rev (3m)-2.17%
Revenue NY rev (1m)-0.42%
Revenue NY rev (3m)-2.01%
Valuation
Industry RankSector Rank
PE 20.48
Fwd PE 18.14
P/S 1.33
P/FCF 18.21
P/OCF 16.95
P/B 5.45
P/tB N/A
EV/EBITDA 13.45
EPS(TTM)2.54
EY4.88%
EPS(NY)2.87
Fwd EY5.51%
FCF(TTM)2.86
FCFY5.49%
OCF(TTM)3.07
OCFY5.9%
SpS39.2
BVpS9.55
TBVpS-4.45
PEG (NY)2.37
PEG (5Y)0.32
Profitability
Industry RankSector Rank
ROA 6.83%
ROE 22.85%
ROCE 14.09%
ROIC 10.97%
ROICexc 11.03%
ROICexgc 23.74%
OM 9.44%
PM (TTM) 5.57%
GM 26.67%
FCFM 7.29%
ROA(3y)7.26%
ROA(5y)5.33%
ROE(3y)23.57%
ROE(5y)17.76%
ROIC(3y)13.05%
ROIC(5y)10.52%
ROICexc(3y)13.27%
ROICexc(5y)10.76%
ROICexgc(3y)30.58%
ROICexgc(5y)28.28%
ROCE(3y)16.76%
ROCE(5y)13.51%
ROICexcg growth 3Y-1.87%
ROICexcg growth 5Y6.48%
ROICexc growth 3Y6.77%
ROICexc growth 5Y19.1%
OM growth 3Y4.39%
OM growth 5Y16.07%
PM growth 3Y18.52%
PM growth 5Y35.35%
GM growth 3Y1.32%
GM growth 5Y2.7%
F-Score6
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF 4
Debt/EBITDA 2.41
Cap/Depr 21.54%
Cap/Sales 0.54%
Interest Coverage 4.84
Cash Conversion 65.44%
Profit Quality 130.86%
Current Ratio 2.25
Quick Ratio 1.3
Altman-Z 3.41
F-Score6
WACC9.82%
ROIC/WACC1.12
Cap/Depr(3y)20.09%
Cap/Depr(5y)16.28%
Cap/Sales(3y)0.48%
Cap/Sales(5y)0.43%
Profit Quality(3y)174.31%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.43%
EPS 3Y44.94%
EPS 5Y64.38%
EPS Q2Q%29.85%
EPS Next Y8.64%
EPS Next 2Y11.67%
EPS Next 3Y9.33%
EPS Next 5Y10.07%
Revenue 1Y (TTM)11.02%
Revenue growth 3Y14.14%
Revenue growth 5Y17.04%
Sales Q2Q%6.57%
Revenue Next Year2.59%
Revenue Next 2Y3.38%
Revenue Next 3Y3.95%
Revenue Next 5Y4.88%
EBIT growth 1Y3.25%
EBIT growth 3Y19.16%
EBIT growth 5Y35.85%
EBIT Next Year28.39%
EBIT Next 3Y13.81%
EBIT Next 5Y11.68%
FCF growth 1Y-32.7%
FCF growth 3YN/A
FCF growth 5Y24.92%
OCF growth 1Y-29.78%
OCF growth 3YN/A
OCF growth 5Y24.63%